HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
about
Role of high-sensitivity C-reactive protein measurements in HIV patientsDifferential adipose tissue gene expression profiles in abacavir treated patients that may contribute to the understanding of cardiovascular risk: a microarray studyHigh-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.Biomarkers and HIV-associated cardiovascular disease.Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy.Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.Lipodystrophy: pathophysiology and advances in treatmentHypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.Treatment of HIV infection in the older patient.HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.HIV infection and stroke: current perspectives and future directionsMarkers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.Cardiovascular disease in HIV infection.Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa?HIV infection and cardiovascular risk in black South Africans.The role of HIV in serious diseases other than AIDS.The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.How does HIV impact on non-AIDS events in the era of HAART?Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study.Untreated HIV infection and large and small artery elasticity.The Relationship Between HIV Infection and Cardiovascular Disease.A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.Endocrine and metabolic abnormalities among HIV-infected patients: a current review.CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.Nanoparticles functionalized with supramolecular host-guest systems for nanomedicine and healthcare.Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.Efavirenz Causes Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Endothelial Cells.Power spectral analysis of heart rate variability in HIV-infected and AIDS patients.SOLUBLE CD40 LIGAND IN DEMENTIA.Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus.Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells.A comparison of the association between glomerular filtration and L-arginine status in HIV-infected and uninfected African men: the SAfrEIC study.Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.Stimulated release of size-selected cargos in succession from mesoporous silica nanoparticles.When do models of NeuroAIDS faithfully imitate "the real thing"?Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.Atherosclerosis and central adiposity in a pediatric patient with AIDS treated with HAART: autopsy findings.
P2860
Q28067891-0EE54469-EAE9-4882-A8D3-A812BB1D746AQ28543075-0231CF82-313A-43CB-A40A-D7F4820A4128Q33556997-BF38D03F-0999-4F32-9940-76F11D975798Q33604765-53506CEA-09E6-45E5-B697-DCEF001E0ECFQ33889580-48468AC8-33B5-4064-86A2-9C5527FCB3D6Q34241388-80D485AA-6C73-4AEE-AA37-8AC1690C5540Q34335486-6FD11FBE-DD42-4BC4-AADB-9F5C2EFC37CBQ34766189-E1507A10-19E4-481A-88B9-FEBCE93FC435Q35089263-3202FE1D-0A9C-4B1E-A3EE-7DF8CD7B6295Q35148915-A44D67D2-0C67-4FAF-A211-DE3D5F79714FQ35176441-2CC040FE-B669-4994-8AF4-6283EA7D7DB3Q35917538-708EB977-48F6-4F2A-9BBC-F4ACDA8E39A4Q35989740-FB10185A-C7C3-4695-A128-CFCCD497A36DQ36285922-98C621A1-5C76-4706-9371-564156125653Q36377944-C4615C23-0DD2-4329-9A31-34E355602C3BQ36408675-C9E5821B-D707-4DF0-9386-476974B11114Q37042012-AEC74390-2972-4415-A51B-FABF22FD2207Q37073341-73647DDC-CB4E-454E-A518-852654FCCC63Q37186467-C5A825FB-0CBE-49B2-9D95-F1AA3B0D5348Q37355492-393A5D33-8BC4-4700-8DCF-5BDEF151E75FQ37356774-5AF63C38-9AEE-451D-98AB-9C509089DBA9Q37381433-7BDE90E4-4B1E-445F-A9B3-FB3D1F3578AEQ37393762-AA255BD2-1044-4B50-9B94-BA165DCC4BAEQ37429096-987F203F-4D3F-4440-9111-BA20D57BD8D5Q38036194-967FFEB9-B9EF-4A97-BC85-2BA1C7DA93ACQ38130907-69ACC3B0-AE01-46B8-AC0B-695058F60524Q38377965-DF60B667-2EE0-43A3-96B1-925A78AB593EQ38495100-88F2F6DE-4145-4B5C-8E4E-C29C89C0E892Q38603237-39CEF548-33D8-4D9A-B0CD-A860C05CF527Q38911295-660A4326-5264-4C2E-B3EE-C7D9FA895DC5Q39743645-AFFABC49-860E-4E25-A1C1-24CD25A83C2DQ39944588-61578389-9849-40EB-B283-EF499CB06C8EQ42234346-CB817F8E-7603-4AE5-A477-BDE3E3282412Q46130631-B429B7C3-37BF-43BB-946E-41EE36178FC3Q46333565-8EDA339B-574D-496A-B865-242AE53B5053Q46792927-01B04668-EDFB-440A-A4DF-7A10CF4ABFABQ47315709-2918183E-2ABD-4D73-8825-DDE147011B60Q47563724-10E5B634-A7E0-4975-B93B-14943B85F80CQ48206030-4E3522CC-67A2-46CA-9221-2B6C5C4799A0Q48340174-C314DCB3-6A0C-4C64-84A5-799082C22E0F
P2860
HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
@ast
HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
@en
type
label
HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
@ast
HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
@en
prefLabel
HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
@ast
HIV infection, HAART, and endothelial adhesion molecules: current perspectives.
@en
P50
P1476
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
@en
P2093
Ricardo Rabagliati
P304
P356
10.1016/S1473-3099(04)00971-5
P577
2004-04-01T00:00:00Z